Phase 2 randomized trial of primary endocrine therapy versus chemotherapy in postmenopausal patients with estrogen receptor-positive breast cancer
DC Element | Wert | Sprache |
---|---|---|
dc.contributor.author | Semiglazov, Vladimir | |
dc.contributor.author | Semiglazov, Vladislav | |
dc.contributor.author | Dashyan, G.A. | |
dc.contributor.author | Ziltsova, E.K. | |
dc.contributor.author | Ivanov, Vadim T. | |
dc.contributor.author | Aa, Bozhok | |
dc.contributor.author | Melnikova, Olga | |
dc.contributor.author | Rm, Paltuev | |
dc.contributor.author | Kletzel, A. | |
dc.contributor.author | Berstein, Lev M. | |
dc.date.accessioned | 2023-07-11T11:27:23Z | - |
dc.date.available | 2023-07-11T11:27:23Z | - |
dc.date.issued | 2007 | |
dc.identifier.uri | http://osnascholar.ub.uni-osnabrueck.de/handle/unios/69818 | - |
dc.subject | Medicine | |
dc.subject | Neoadjuvant therapy | |
dc.subject | Chemotherapy | |
dc.subject | Internal medicine | |
dc.subject | Anastrozole | |
dc.subject | Aromatase | |
dc.subject | Oncology | |
dc.subject | Breast cancer | |
dc.subject | Exemestane | |
dc.subject | Cancer | |
dc.title | Phase 2 randomized trial of primary endocrine therapy versus chemotherapy in postmenopausal patients with estrogen receptor-positive breast cancer | |
dc.type | journal article | |
dc.identifier.doi | https://doi.org/10.1002/cncr.22789 | |
dc.description.volume | 110 | |
dc.description.issue | 2 | |
dc.description.startpage | 244 | |
dc.description.endpage | 254 | |
dc.identifier.external | https://openalex.org/W2058585724 | |
local.import.sourcefile | openalex_20230710.ris | |
local.rawaffiliation | null |